STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

SAB Biotherapeutics, Inc.

Filed

November 28, 2023

Period of Report

November 24, 2023

Accession Number

0001062993-23-021502